Outcomes of Stereotactic vs Conventional Radiation Therapy in Unresectable Pancreatic Cancer: A Real-World Retrospective Analysis
Applied Radiation Oncology · 2026-07 · 15 (2) · 1-7
DOI: 10.37549/aro-d-26-0006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Radiation Oncology, 2026-07. Verfasst von Daniel Tesolin und 2 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objectives: Unresectable pancreatic cancer (UPC) has poor outcomes, and the role of radiation therapy (RT) remains incompletely defined. This retrospective study evaluated real-world outcomes following primary tumor-directed RT in UPC and compared outcomes across different RT approaches. Materials and Methods: We retrospectively identified 176 patients who underwent local RT for UPC between August 2007 and December 2022 at a single institution. 14 patients were excluded due to repeat RT, incomplete RT, or lack of follow-up, leaving 162 patients. Patients were stratified into cohorts by RT technique: conventionally fractionated RT (CFRT; >15 fractions) (n = 22, 14%), hypofractionated RT (HypoRT; ≤15 fractions and EQD2
Zitieren
APA
Tesolin, D., Seguin, J., & Nair, V. (2026). Outcomes of Stereotactic vs Conventional Radiation Therapy in Unresectable Pancreatic Cancer: A Real-World Retrospective Analysis. Applied Radiation Oncology, 15(2), 1-7. https://doi.org/10.37549/aro-d-26-0006
Vancouver
Tesolin D, Seguin J, Nair V. Outcomes of Stereotactic vs Conventional Radiation Therapy in Unresectable Pancreatic Cancer: A Real-World Retrospective Analysis. Applied Radiation Oncology. 2026;15(2):1-7. doi:10.37549/aro-d-26-0006
BibTeX
@article{Tesolin2026,
author = {Tesolin, Daniel and Seguin, Jeanne and Nair, Vimoj},
title = {Outcomes of Stereotactic vs Conventional Radiation Therapy in Unresectable Pancreatic Cancer: A Real-World Retrospective Analysis},
journal = {Applied Radiation Oncology},
year = {2026},
volume = {15},
number = {2},
pages = {1--7},
doi = {10.37549/aro-d-26-0006}
}
EUVIMED